-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, CanSino bioinspiration with recombinant new coronavirus vaccine (type 5 adenovirus vector) Kwesa ® Wuyou ®, after the National Health Commission made a recommendation, the State Drug Administration organized and agreed to be included in the emergency use
On the basis of the intramuscular adenovirus vector new crown epidemic, Kwesa ® ® Misty ® Innovates the administration method, uses a nebulizer to atomize the seedlings into tiny particles, and completes the inoculation
In March 2021, Kwesa ® Mist Was ® Approved for Drug Clinical Trials by the State Drug Administration for the prevention of diseases caused by novel coronavirus infection (COVID-19
At present, CanSino Bio has achieved stable production of a variety of innovative vaccines and established a commercial supply system
A few days ago, CanSino bioinspiration with recombinant new coronavirus vaccine (type 5 adenovirus vector) Kwesa ® Wuyou ®, after the National Health Commission made a recommendation, the State Drug Administration organized and agreed to be included in the emergency use
On the basis of the intramuscular adenovirus vector new crown epidemic, Kwesa ® ® Misty ® Innovates the administration method, uses a nebulizer to atomize the seedlings into tiny particles, and completes the inoculation
In March 2021, Kwesa ® Mist Was ® Approved for Drug Clinical Trials by the State Drug Administration for the prevention of diseases caused by novel coronavirus infection (COVID-19
At present, CanSino Bio has achieved stable production of a variety of innovative vaccines and established a commercial supply system
If this article violates your rights, please contact us
